SCHEMBL19442030

SCHEMBL19442030

COc1ccc(C(=O)OCCN(C)C)o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.50
▸ GAA P10253 2/20 0.50
▸ PHLPP2 Q6ZVD8 1/20 0.48
▸ HSD17B10 Q99714 3/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ MAPT P10636 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.41
▸ LMNA P02545 3/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ MAOA P21397 1/20 0.40
▸ CNR1 P21554 1/20 0.40
▸ DRD4 P21917 1/20 0.40
▸ ACHE P22303 1/20 0.40
▸ HRH2 P25021 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ NTSR1 P30989 1/20 0.40
▸ HRH1 P35367 1/20 0.40
▸ DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19981453 0.84 HTT (0.51) ALDH1A1GAAPHLPP2HSD17B10MAPK1
SCHEMBL28817945 0.83 ALDH1A1 (0.47) ALDH1A1MAPK1MAPTSMN1; SMN2KDM4E
SCHEMBL19442031 0.81 HTT (0.40) ALDH1A1HSD17B10MAPTSMN1; SMN2KDM4E
SCHEMBL991408 0.81 MEN1 (0.63) ALDH1A1PHLPP2HSD17B10MAPK1MAPT
SCHEMBL11985077 0.80 TSHR (0.50) ALDH1A1HSD17B10MAPK1SMN1; SMN2LMNA
SCHEMBL28817917 0.79 HDAC4 (0.57) ALDH1A1GAAHSD17B10MAPTKDM4E
SCHEMBL19981293 0.77 ALDH1A1 (0.49) ALDH1A1GAAPHLPP2HSD17B10MAPK1
SCHEMBL19825337 0.76 TSHR (0.45) ALDH1A1MAPK1MAPTCYP1A2
SCHEMBL19825409 0.75 TSHR (0.44) ALDH1A1MAPK1MAPT
SCHEMBL19442049 0.75 HTT (0.58) ALDH1A1GAAMAPTKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9782382-B2 TOFA analogs useful in treating dermatological disorders or conditions DERMIRA (CANADA), INC. (US) 2017-10-10 — — US disclosed
Send feedback